Pharmaceutical raw material Dihydrostreptomycin sulfate
| Name: |
Dihydrostreptomycin Sulphate |
| Molecular Formula: |
C42H88N14O36S3 |
| Molecular Weight: |
1461.4153 |
| Boiling point: |
954.5°C at 760 mmHg |
| Flash point: |
531.1°C |
| Vapour Pressur: |
0mmHg at 25°C |
| Appearance: |
white crystalline powder. |
| Product name |
Streptomycin sulfate |
 |
| CAS: |
3810-74-0 |
| MF: |
C42H84N14O36S3 |
| MW: |
1457.38 |
| EINECS: |
223-286-0 |
|
- Streptomycin sulfate is the sulfate form of streptomycin. Streptomycin class antibiotics are produced by the soil-living Actinomyces Streptomyces. Streptomycin is the first emerging drug which has been proven to be an effective chemotherapy drug in treating tuberculosis. This product must be injected intramuscularly which makes it be limited for long-term application. Streptomycin, obtained from Streptomyces, is currently the most effective and also the least toxic antibiotics for application outside the gastrointestinal tract.This product is a kind of fungicides which may be due to its direct effect on the bacterial ribosome, and the resulting effective inhibition of protein synthesis. It is mainly used for treating extracellular (including the cavity) Mycobacterium tuberculosis.
|
Antibiotic drugs, mainly used for solid violet stain negative bacilli infection, also can be used for tuberculosis bacilli infection.
